Clinical Trials Browser

Phase 1 × dinutuximab × 30 days × Clear all

NCT01711554 2026-03-18

Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma

Phase 1 Active not recruiting

Neuroblastoma